Tumor cells increase GLS and glutamine transporter levels, enabling tumor cells to acquire large amounts of energy and biomacromolecules through glutamine catabolism, leading to glutamine addiction in various cancer types, including myeloma and glioma [21]. Here, GLS is linked to neoplasm.